Diagnosis of endometrial carcinoma made easier by analysis of mutations in cervix or endometrial tissue.
A study recently published in the Journal of Clinical Oncology reported on the association between power morcellation and mortality in women with unexpected uterine cancer who were undergoing a hysterectomy or myomectomy.
Immunotherapy could replace chemotherapy in some patients with recurrent/metastatic cervical and vaginal or vulvar cancers.
The US Food and Drug Administration recently approved a new indication for olaparib for maintenance treatment in adult patients with germline or somatic BRCA-mutated advanced epithelial ovarian cancer.
How much do you know about predicting patient outcomes in ovarian cancer? Take our latest quiz to test your knowledge.